•  
  •  
  •  
  •  

2026-08-11 13:40:52

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra

Keywords Selected:  UKMHRA

Stock Report

  • Relonchem Limited receives Marketing Authorization for its two products
  • Relonchem Limited receives Marketing Authorization for two of its products
  • Relonchem Limited receives Marketing Authorization for its products
  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Biocon Biologics receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars
  • BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK
  • Relonchem Limited receives Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA
  • Aarti Drugs Ltd's subsidiary receives CGMP certificate from UK MHRA
  • Relonchem Limited receives Marketing Authorization from UKMHRA for its products
  • UK Relonchem Ltd, receives Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets
  • Relonchem Limited receives UKMHRA Marketing Authorization for its products
  • Relonchem Ltd receives Marketing Authorisation for the product Levetiracetam Relonchem 100 mg/mL Oral Solution
  • Sentynl Therapeutics receives marketing authorization for NULIBRY® from the UK MHRA for treatment of MoCD Type A
  • Biocon Biologics Receives MHRA, UK Approval for YESAFILI®, Biosimilar Aflibercept
  • UK MHRA renews GMP compliance of Kopran Ltd's two plants
  • Shilpa Medicare receives UK‐MHRA Approval for Betahistine Dihydrochloride Orodispersible Films, 24 mg
  • Lupin announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities
  • Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
  • Lupin announces UK MHRA Approval of Lutio® for Treatment of COPD
  • Shilpa Medicare Limited, Unit VI, Bengaluru facility has been issued UK MHRA GMP
  • Brooks Steriscience Ltd recieves UK MHRA marketing authorization for Meropenem Injection
  • Marksans Pharma announces UK MHRA approval for Bells Healthcare All in One Oral Solution
  • Marksans Pharma Limited announces UK MHRA approval for Loperamide 2mg Hard Capsules
  • FDC Limited receives GMP certificate

Latest Post

  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025